DP

Dennis Podlesak

Venture Capitalist, Canaan Partners’ Axcelius

New York, New York

Investor
VC

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Lists including Dennis

AM
AR
AG
AH

Based in NYC

2600 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Investments

Syndax Pharmaceuticals

Series A

Total Funding: $180M

RightCare Solutions

Series A

Total Funding: $7M

Kalidex Pharmaceuticals

Series Unknown

Total Funding: $7M

Work Experience

Canaan Partners’ Axcelius

2019

  • CEO & Managing Partner

    2019

Domain Associates

2007

  • Venture Capitalist

    2007